Ocular Therapeutix OCUL
NASDAQ OCUL
$7.66 -1.99 (-20.67%)
At close: Sep 28, 2026 · 4:00 PM EDT

Ocular Therapeutix (OCUL) Invested Capital (2013 - 2026)

Updated

Ocular Therapeutix (OCUL) recorded Invested Capital of $592.84 million in Q2 2026, up 57.7% from $375.82 million a year earlier but down 9.3% from the prior quarter.

Analysis

Ocular Therapeutix (OCUL) Invested Capital (2013 - 2026) Analysis & Trends

For FY2025, Ocular Therapeutix reported Invested Capital of $725.65 million, up 89.0% from FY2024.

  • Annual Invested Capital has increased for three straight years, with a five-year compound annual growth rate of 48.3% (FY2020 to FY2025).
  • Across earlier years, Invested Capital came in at $383.85 million in FY2024 (+144.6%), $156.92 million in FY2023 (+158.8%), $60.64 million in FY2022 (-46.3%) and $113 million in FY2021 (+11.5%).
  • Quarterly Invested Capital has ranged from $28.47 million in Q2 2023 to $725.65 million in Q4 2025 over the past five years.
  • On a year-over-year basis, Invested Capital has increased for three consecutive quarters, with growth averaging 99.4% over the last eight quarters.
  • Peak year-over-year performance for Invested Capital in the last five years was growth of 475.3% in Q3 2024, against a decline of 68.7% in Q2 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $653.64 million (Q1 2026), $725.65 million (Q4 2025) and $328.85 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn 134.01 Bn
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn 64.89 Bn
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn 95.89 Bn
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn 79.44 Bn
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn 50.26 Bn
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn 68.99 Bn
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn 38.08 Bn
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn 148.69 Bn
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn -
10 Ocular Therapeutix 2.12 Bn 2.12 Bn 11.46 Mn 592.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 592.84 Mn
Mar 31, 2026 653.64 Mn
Dec 31, 2025 725.65 Mn
Sep 30, 2025 328.85 Mn
Jun 30, 2025 375.82 Mn
Mar 31, 2025 335.13 Mn
Dec 31, 2024 383.85 Mn
Sep 30, 2024 419.84 Mn
Jun 30, 2024 444.83 Mn
Mar 31, 2024 474.44 Mn
Dec 31, 2023 156.92 Mn
Sep 30, 2023 72.98 Mn
Jun 30, 2023 28.47 Mn
Mar 31, 2023 35.03 Mn
Dec 31, 2022 60.64 Mn
Sep 30, 2022 71.42 Mn
Jun 30, 2022 90.93 Mn
Mar 31, 2022 104.86 Mn
Dec 31, 2021 113.00 Mn
Sep 30, 2021 112.28 Mn
API Access

Ocular Therapeutix Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=OCUL&period=max&api_key=YOUR_API_KEY